Stockreport

Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears [Yahoo! Finance]

Jade Biosciences, Inc.  (JBIO) 
PDF JADE101 (anti-APRIL) : A Phase 1 healthy-volunteer readout is expected in the first half of the year, and Jade says JADE101 is a femtomolar APRIL binder (claimed 750x p [Read more]